These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35834159)

  • 1. Prevalence of Malaria and Covid-19 in Febrile Patients in Lomé, Togo in 2020.
    Dorkenoo AM; Gbeasor-Komlanvi FA; Gbada K; Zida-Compaore WIC; Teou D; Konu YR; Lack F; Sadio AJ; Tchankoni MK; Dagnra AC; Ekouevi DK
    Acta Parasitol; 2022 Sep; 67(3):1335-1342. PubMed ID: 35834159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021.
    Sadio AJ; Ferré VM; Konu RY; Dagnra AC; Descamps D; Ekouevi DK; Charpentier C
    BMC Infect Dis; 2023 Apr; 23(1):200. PubMed ID: 37013507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
    Halatoko WA; Konu YR; Gbeasor-Komlanvi FA; Sadio AJ; Tchankoni MK; Komlanvi KS; Salou M; Dorkenoo AM; Maman I; Agbobli A; Wateba MI; Adjoh KS; Goeh-Akue E; Kao YB; Kpeto I; Pana P; Kinde-Sossou R; Tamekloe A; Nayo-Apétsianyi J; Assane SH; Prine-David M; Awoussi SM; Djibril M; Mijiyawa M; Dagnra AC; Ekouevi DK
    PLoS One; 2020; 15(11):e0242124. PubMed ID: 33166369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 in patients presenting with malaria-like symptoms at a primary healthcare facility in Accra, Ghana.
    Asamoah I; Adusei-Poku M; Vandyck-Sey P; Steele-Dadzie A; Kuffour AS; Turkson A; Asante IA; Addo-Osafo K; Mohktar Q; Adu B; Afrane YA; Sagoe KWC
    PLoS One; 2024; 19(2):e0298088. PubMed ID: 38335209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of dengue fever in patients with febrile syndrome at the Sylvanus Olympio Teaching Hospital of Lomé (Togo) in 2017].
    Salou M; Zida-Compaoré WIC; Gbeasor-Komlanvi FA; Folly-Gbogboe M; Konou AA; Dossim S; Mama Z; M D; Ekouevi DK; Y Dagnra A
    Med Trop Sante Int; 2021 Dec; 1(4):. PubMed ID: 35685859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021.
    Lyimo E; Fougeroux C; Malabeja A; Mbwana J; Hayuma PM; Liheluka E; Turner L; Gesase S; Lavstsen T; Lusingu JPA; Minja DTR; Wang CW
    BMC Infect Dis; 2022 Nov; 22(1):846. PubMed ID: 36371172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the performance of advantage P.f. malaria Card
    Teou DC; Dorkenoo AM; Ataba E; Alidou S; Yakpa K; Abdou-Kerim A; Maman I; Agbonon A
    Parasit Vectors; 2023 Nov; 16(1):444. PubMed ID: 38037186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections.
    Yansouni CP; Papenburg J; Cheng MP; Corsini R; Caya C; Vasquez Camargo F; Harrison LB; Zaharatos G; Büscher P; Faye B; Ndiaye M; Matlashewski G; Ndao M
    J Clin Microbiol; 2022 Jan; 60(1):e0171721. PubMed ID: 34669455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of two COVID-19 antigenic diagnostic tests:
    Ngaba GP; Kalla GCM; Assob JCN; Njouendou AJ; Jembe CN; Mboudou ET; Mbopi-Keou FX
    Pan Afr Med J; 2021; 39():228. PubMed ID: 34630840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of dengue and COVID-19 antibody rapid diagnostic tests cross-reactivity in Indonesia.
    Santoso MS; Masyeni S; Haryanto S; Yohan B; Hibberd ML; Sasmono RT
    Virol J; 2021 Mar; 18(1):54. PubMed ID: 33706767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross sectional study of dengue virus infection in febrile patients presumptively diagnosed of malaria in Maiduguri and Jos plateau, Nigeria.
    Onyedibe K; Dawurung J; Iroezindu M; Shehu N; Okolo M; Shobowale E; Afolaranmi T; Dahal S; Maktep Y; Pama P; Isa S; Egah D
    Malawi Med J; 2018 Dec; 30(4):276-282. PubMed ID: 31798807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of the Simtomax® CoronaCheck rapid diagnostic test.
    Ducrest PJ; Freymond A; Segura JM
    J Virol Methods; 2021 Aug; 294():114178. PubMed ID: 33961910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
    Peghin M; Bontempo G; De Martino M; Palese A; Gerussi V; Graziano E; Fabris M; D'Aurizio F; Sbrana F; Ripoli A; Curcio F; Isola M; Tascini C
    BMC Infect Dis; 2022 Oct; 22(1):810. PubMed ID: 36316641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings.
    Aguilar R; Jiménez A; Santano R; Vidal M; Maiga-Ascofare O; Strauss R; Bonney J; Agbogbatey M; Goovaerts O; Boham EEA; Adu EA; Cuamba I; Ramírez-Morros A; Dutta S; Angov E; Zhan B; Izquierdo L; Santamaria P; Mayor A; Gascón J; Ruiz-Comellas A; Molinos-Albert LM; Amuasi JH; Awuah AA; Adriaensen W; Dobaño C; Moncunill G
    J Med Virol; 2024 Jun; 96(6):e29713. PubMed ID: 38874194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
    Saeed AY; Assafi MS; Othman HE; Shukri HM
    J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.